VALVULOPATHIE CARDIAQUE SEVERE SECONDAIRE A LA CABERGOLINE REVERSIBLE APRES L'ARRET DU MEDICAMENT :A PROPOS D?UN CAS
Journal: International Journal of Advanced Research (Vol.6, No. 12)Publication Date: 2018-12-01
Authors : H. Moata g. El mghari; n.el Ansari.;
Page : 900-903
Keywords : International Journal of Advanced Research (IJAR);
Abstract
Nous rapportons lecasd'unepatiente de 34 ans consultant pour un ad?nomehypophysaire de 2,2 cm en contact avec le chiasmaoptique. La patiente a ?t?trait?avec 1 mg / semaine de Cabergoline (agonistedopaminergique DA) et a d?velopp?unevalvulopathietricuspidestade III qui a ensuite?t?r?versible apr?s l'arr?t du traitementpar la Cabergoline .
Other Latest Articles
- A STUDY TO COMPARE THE EFFECTIVENESS IN REDUCTION OF PAIN LEVEL BETWEEN SIMPLE INTRAVENOUS CANNULATION AND PRO-SAFETY INTRAVENOUS CANNULATION
- MAINTAINING GURAGINA LANGUAGE WITH REFERENCE TO STATUS AND ATTITUDE
- METAFICTITONAL NARRATIVE QUALITIES OF CHIMERA
- PROGRESSIVE FAMILIAL HEART BLOCK ASSOCIATED WITH A MUTATION IN GENE TRPM4: A MOROCCAN FAMILY CASE
- SAFETY IMPROVEMENT THOUGHTS IN MINING INDUSTRIES
Last modified: 2019-01-16 18:11:08